Impact of a Novel, Customized and Structured Exercise Prescription for Cardiometabolic Diseases in India: A Mixed-Methods Study and Randomized Controlled Trial.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2025
Project Lead
Pranathi R
Authors
Pranathi R, Denis Xavier, Jerin Cherian
Project Status
ongoing
Project Type
Mixed- Methods Study (AcSiR- DHR PhD Fellow 2025)